7 july 2026 Punjab Khabarnama Bureau Eye specialists are advocating for the greater integration of genetic testing and genomic medicine into glaucoma care, saying it could transform the early detection, diagnosis, and treatment of one of the world’s leading causes of irreversible blindness. Experts believe that understanding a patient’s genetic profile can help identify those at higher risk and enable more personalized treatment strategies.
Glaucoma is a group of eye diseases that damage the optic nerve, often due to increased pressure inside the eye. Because the condition usually develops gradually and without noticeable symptoms in its early stages, many patients remain unaware they have the disease until significant vision loss has already occurred.
Role of Genetics in Glaucoma
Doctors explain that genetics plays a significant role in several forms of glaucoma. Individuals with a family history of the disease have a substantially higher risk of developing it than those without affected relatives.
Advances in genetic research have identified several genes associated with glaucoma, helping researchers better understand why some people are more susceptible. Specialists say genetic screening could help identify high-risk individuals before symptoms appear, allowing for earlier monitoring and timely intervention.
Importance of Early Detection
Since vision loss caused by glaucoma cannot be reversed, early diagnosis is essential. Routine comprehensive eye examinations remain the most effective way to detect the disease before permanent damage occurs.
Doctors believe combining traditional eye tests with genetic risk assessment could improve screening programmes, particularly for people with a strong family history, those over the age of 40, and individuals with other risk factors such as diabetes or high eye pressure.
Towards Personalized Treatment
Genetic information may also help ophthalmologists tailor treatment plans according to an individual’s specific risk profile. Some patients may require closer follow-up, earlier medication, or surgical intervention depending on their genetic predisposition and disease progression.
Researchers say precision medicine could improve treatment outcomes while reducing unnecessary interventions for patients at lower risk.
Growing Research and Future Possibilities
Scientists continue to investigate how genetic discoveries can lead to new therapies that directly target the biological mechanisms responsible for glaucoma. Future treatments may include gene-based therapies or medicines designed for specific genetic mutations, although such approaches remain under development.
Experts caution that genetic testing should complement—not replace—standard clinical examinations and imaging tests.
Raising Public Awareness
Doctors are encouraging people, particularly those with a family history of glaucoma, to undergo regular eye check-ups even if they have no symptoms. Public awareness remains crucial because glaucoma often progresses silently until vision has been permanently affected.
Maintaining healthy lifestyle habits, controlling chronic conditions such as diabetes and hypertension, and seeking prompt medical attention for vision changes can also support overall eye health.
A Step Towards Better Eye Care
The growing emphasis on genetics reflects a broader shift toward precision medicine in healthcare. Specialists believe that incorporating genetic insights into glaucoma management could improve prevention, enable earlier diagnosis, and preserve vision for thousands of patients.
While further research is needed before genetic testing becomes routine in glaucoma care, experts say the approach has the potential to reshape how the disease is detected and treated in the future.